BridgeMD
New treatment option for Hallucinations, Auditory
Official title VR-based Avatar Therapy for Treatment of Auditory Hallucinations
ClinicalTrials.gov ID: NCT06505564
What this study is testing
- What it's testing
- The primary aim of this study is to evaluate the safety and efficacy of AVATAR therapy, developed to address residual auditory hallucinations persisting despite medication in schizophrenia spectrum disorder. The intervention aims to reduce the intensity and frequency of these symptoms, as well as alleviate associated depressive and anxiety symptoms, using a virtual reality (VR)-assisted intervention developed for this purpose by the Danish company HEKA VR.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of schizophrenia spectrum disorder according to DSM-5,
- Age 18 or older,
- The fluent use of the spoken language at the site (Hungarian/Spanish/Polish),
- Informed consent provided by the patient or their caregiver after being informed about the research procedure
- Stable medication dosage for at least 4 weeks prior to recruitment,
You likely can't join if
- Inability to identify a single dominant voice that is the subject of the intervention,
- Lack of cooperation,
- Intellectual disability based on medical history,
- Regular substance abuse
- Central nervous system injury or neurological disease that affects cognitive performance,
- Suicidal risk
See the full eligibility criteria
- Diagnosis of schizophrenia spectrum disorder according to DSM-5,
- Age 18 or older,
- The fluent use of the spoken language at the site (Hungarian/Spanish/Polish),
- Informed consent provided by the patient or their caregiver after being informed about the research procedure
- Stable medication dosage for at least 4 weeks prior to recruitment,
- Regular psychiatric follow-up,
- Experience of auditory hallucinations for at least three months (PANSS hallucination score of at least 3 points),
- Meeting the remission criteria described by Andreasen, except for the score related to auditory hallucinations
- Inability to identify a single dominant voice that is the subject of the intervention,
- Lack of cooperation,
- Intellectual disability based on medical history,
- Regular substance abuse
- Central nervous system injury or neurological disease that affects cognitive performance,
- Suicidal risk
- Aversion to virtual reality,
- Severe visual impairment
The study team makes the final eligibility decision.
Where it's taking place
- Budapest, Hungary
- Lodz, Poland
- Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Budapest, Hungary; Lodz, Poland; Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.